Ondansetron
NDC 71335-3073, Ondansetron, tablet, orally disintegrating, from Bryant Ranch Prepack.
- Product NDC
- 71335-3073
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-3073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-3073-0 | 71335307300 | 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-0) |
| 71335-3073-1 | 71335307301 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-1) |
| 71335-3073-2 | 71335307302 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-2) |
| 71335-3073-3 | 71335307303 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-3) |
| 71335-3073-4 | 71335307304 | 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-4) |
| 71335-3073-5 | 71335307305 | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-5) |
| 71335-3073-6 | 71335307306 | 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-6) |
| 71335-3073-7 | 71335307307 | 12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-7) |
| 71335-3073-8 | 71335307308 | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-8) |
| 71335-3073-9 | 71335307309 | 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/77397df5-5a4f-41b2-98bc-f817a1e497fc
Use it
Look up 71335-3073 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-3073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-3073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.